- Home
- PDX vs DNA Comparison
PDX vs DNA Comparison
Compare PDX & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDX
- DNA
- Stock Information
- Founded
- PDX 2019
- DNA 2008
- Country
- PDX NY
- DNA United States
- Employees
- PDX N/A
- DNA N/A
- Industry
- PDX Finance/Investors Services
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PDX Finance
- DNA Health Care
- Exchange
- PDX Nasdaq
- DNA Nasdaq
- Market Cap
- PDX 1.0B
- DNA 452.9M
- IPO Year
- PDX N/A
- DNA N/A
- Fundamental
- Price
- PDX $23.28
- DNA $5.64
- Analyst Decision
- PDX
- DNA Sell
- Analyst Count
- PDX 0
- DNA 6
- Target Price
- PDX N/A
- DNA $55.80
- AVG Volume (30 Days)
- PDX N/A
- DNA 1.7M
- Earning Date
- PDX 01-01-0001
- DNA 08-08-2024
- Dividend Yield
- PDX 4.95%
- DNA N/A
- EPS Growth
- PDX N/A
- DNA N/A
- EPS
- PDX N/A
- DNA N/A
- Revenue
- PDX N/A
- DNA $184,335,000.00
- Revenue This Year
- PDX N/A
- DNA N/A
- Revenue Next Year
- PDX N/A
- DNA $16.69
- P/E Ratio
- PDX N/A
- DNA N/A
- Revenue Growth
- PDX N/A
- DNA N/A
- 52 Week Low
- PDX $13.52
- DNA $5.64
- 52 Week High
- PDX $21.05
- DNA $86.80
- Technical
- Relative Strength Index (RSI)
- PDX 62.60
- DNA 28.61
- Support Level
- PDX $22.62
- DNA $6.00
- Resistance Level
- PDX $23.59
- DNA $9.33
- Average True Range (ATR)
- PDX 0.33
- DNA 0.82
- MACD
- PDX 0.06
- DNA -0.07
- Stochastic Oscillator
- PDX 74.29
- DNA 0.00
About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest
PIMCO Dynamic Income Strategy Fund is a non-diversified, limited term, closed-end management investment company registered under the Investment Company. The fund's primary investment objective is to seek current income as a primary objective and capital appreciation as a secondary objective.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.